References
Wilens TE, Biederman J, Spencer TJ. Pharmacotherapy of attention deficit hyperactivity disorder in adults. CNS Drugs 1998 May; 9(5): 347–56
Fargason RE, Ford CV. Attention deficit hyperactivity disorder in adults: diagnosis, treatment and prognosis. South Med J 1994 Mar; 87(3): 302–9
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994
British National Formulary. No. 36. London: The Pharmaceutical Press, 1998 Sep
Wender PH, Reimherr FW. Bupropion treatment of attention deficit hyperactivity disorder in adults. Am J Psychiatry 1990; 147: 1018–20
Wilens TE, Biederman J. The stimulants. Psychiatr Clin North Am 1992; 15(1): 191–222
Langer DH, Sweeney KP, Bartenbach DE, et al. Evidence of lack of abuse or dependence following pemoline treatment: results of a retrospective survey. Drug Alcohol Depend 1986; 17: 213–27
Wilens TE, Biederman J, Mick E, et al. A systematic assessment of tricyclic antidepressants in the treatment of adult attention deficit hyperactivity disorder. J Nerv Ment Dis 1995; 184: 48–50
Wilens TE, Biederman J, Prince J, et al. A double-blind, placebo-controlled trial of desipramine for adults with ADHD. Am J Psychiatry 1996; 153: 1147–53
Wender PH, Wood DR, Reimherr FW, et al. An open trial of pargyline in the treatment of attention deficit disorder, residual type. Psychiatry Res 1983; 9: 329–36
Wender PH, Wood DR, Reimherr FW. Pharmacological treatment of attention deficit disorder residual type (ADD.RT, ‘minimal brain dysfunction’, ‘hyperactivity’) in adults. Psychopharmacol Bull 1985; 21: 222–30
Ernst M, Liebenauer L, Jons P, et al. Selegiline in adults with attention deficit hyperactivity disorder: clinical efficacy and safety. Psychopharmacol Bull 1996; 32: 327–34
Mattes JA. Propranolol for adults with temper outbursts and residual attention deficit disorder. J Clin Psychopharmacol 1986; 6: 299–302
Conners C, Levin ED, Sparrow E, et al. Nicotine and attention in adult attention deficit hyperactivity disorder. Psychopharmacol Bull 1996; 32: 67–73
Gammon GD, Brown TE. Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder. J Child Adolesc Psychopharmacol 1993;3: 1–10
Ratey J, Greenberg M, Lindem K. Combination of treatments for attention deficit disorders in adults. J Nerv Ment Dis 1991; 176: 699–701
Rights and permissions
About this article
Cite this article
Methylphenidate still first line, but combination treatment often required in adults with attention deficit hyperactivity disorder. Drugs Ther. Perspect 13, 8–12 (1999). https://doi.org/10.2165/00042310-199913030-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199913030-00004